Equities

Fuji Pharma Co Ltd

Fuji Pharma Co Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (JPY)1,374.00
  • Today's Change33.00 / 2.46%
  • Shares traded128.70k
  • 1 Year change-4.72%
  • Beta0.7476
Data delayed at least 20 minutes, as of Nov 14 2024 04:59 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Cash flow Back to Overview

In millions of JPY
(except for per share items)
Fiscal data as of Sep 30 2024202420232022
OPERATIONS
Net income8,2764,3993,723
Depreciation/depletion3,3432,7072,462
Non-Cash items(3997)(556)(175)
Cash taxes paid, supplemental1,0269461,498
Cash interest paid, supplemental19410482
Changes in working capital(3805)(4947)(6952)
Total cash from operations4,1511,919(659)
INVESTING
Capital expenditures(4372)(3897)(12423)
Other investing and cash flow items, total2,714(1343)1,152
Total cash from investing(1658)(5240)(11271)
FINANCING
Financing cash flow items10.00(1)(1)
Total cash dividends paid(972)(899)(729)
Issuance (retirement) of stock, net45----
Issuance (retirement) of debt, net4812,8155,824
Total cash from financing(435)1,9155,094
NET CHANGE IN CASH
Foreign exchange effects202185183
Net change in cash2,260(1221)(6653)
Net cash-begin balance/reserved for future use2,3243,54610,199
Net cash-end balance/reserved for future use4,5852,3243,546
SUPPLEMENTAL INCOME
Depreciation, supplemental3,3432,7072,462
Cash interest paid, supplemental19410482
Cash taxes paid, supplemental1,0269461,498
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.